한글목차

세계의 분자 측정법 시장의 미래는 장비, 시약·소모품, 서비스 시장에서의 기회로 유망시되고 있습니다. 세계의 분자 측정법 시장은 2025-2031년에 CAGR 6.1%로 성장할 것으로 예상되고 있습니다. 이 시장의 주요 촉진요인은 맞춤형 의료에 대한 수요 증가와 유전체학 및 생명공학 분야의 연구 증가입니다.

• Lucintel은 유형별로는 중합효소 연쇄반응(PCR)이 예측 기간 중 가장 높은 성장세를 보일 것으로 예측했습니다.
• 용도별로는 시약 및 소모품이 가장 높은 성장이 예상됩니다.
• 지역별로는 아시아태평양이 예측 기간 중 가장 높은 성장을 보일 것으로 예측됩니다.

분자 측정법 시장의 새로운 동향

분자 측정법 시장은 기술의 발전과 다양한 산업 분야에서의 응용 증가로 인해 빠르게 진화하고 있습니다. 여러 가지 상황이 상황을 재구성하고, 진단 능력을 강화하고, 분자 측정법의 범위를 확장하고 있습니다.

• 분자진단에 인공지능(AI)의 통합: AI는 데이터 분석과 해석의 정확성을 향상시킴으로써 분자진단학에 변화를 가져오고 있습니다. PCR이나 NGS와 같은 분자 기법과 결합하면 AI 알고리즘은 유전자 데이터의 패턴을 파악할 수 있으며, 암이나 유전성 질환과 같은 질병을 보다 효과적으로 진단하는 데 도움이 될 수 있습니다. AI를 활용한 솔루션은 검사 속도 향상과 인적 오류 감소에 활용되고 있으며, 의료 서비스 프로바이더는 보다 신속하고 정확한 판단을 내릴 수 있게 되었습니다. AI 기술이 계속 발전함에 따라 분자진단학에 혁명을 초래하는 중요한 역할을 할 것으로 보입니다.
• 차세대 염기서열분석(NGS) 활용 확대: NGS 기술은 특히 종양학, 유전학, 희귀질환에서 유전자 조사에서 임상 진단으로 확대되고 있습니다. NGS는 보다 종합적이고 상세한 유전자 분석을 가능하게 하여 정밀의료를 실현합니다. NGS 플랫폼의 가격이 저렴해지고 이용이 쉬워짐에 따라 임상 현장에서의 이용이 촉진되어 질병의 조기 발견과 개인별 맞춤 치료 계획을 세우기 쉬워지고 있습니다. 유전자 데이터가 증가함에 따라 NGS는 분자진단 및 치료 정책 결정에 있으며, 중요한 툴이 되고 있습니다.
• 현장 분자진단: 특히 COVID-19 팬데믹 상황에서 신속한 현장 검사의 필요성에 따라 현장 분자진단(POC)에 대한 수요가 증가하고 있습니다. 이러한 휴대용 장비는 검사실이 필요 없이 즉시 검사 및 결과를 얻을 수 있으므로 지방이나 의료서비스가 부족한 지역에서 특히 유용합니다. POC 분자진단법은 감염성 질환 검출, 유전자 검사, 만성질환 모니터링에 점점 더 많이 사용되고 있습니다. 분자진단 툴의 소형화 추세는 검사를 보다 친숙하고 효율적으로 만들어 이 부문의 성장을 가속할 것으로 보입니다.
• 분자진단을 위한 CRISPR 기술의 발전: CRISPR 유전자 편집 기술은 특정 유전자 염기서열을 보다 정확하고 효율적으로 검출할 수 있게 함으로써 분자진단학에 혁명을 일으키고 있습니다. 연구개발은 병원체 및 유전자 변이를 신속하고 정확하게 검출할 수 있는 CRISPR 기반 진단 툴을 개발하고 있습니다. 이러한 발전은 질병의 조기 발견을 개선하고 맞춤형 의료를 위한 잠재적인 해결책을 제공할 것으로 기대됩니다. CRISPR을 분자진단에 통합하는 것은 더 빠르고 저렴한 진단 툴을 실현하는 중요한 추세로, 의료와 농업 모두에 혜택을 가져다 줄 것입니다.
• 환경 모니터링의 분자 기법: 환경 모니터링에서 분자 기법의 활용이 확대되고 있으며, 그 적용 범위는 수중 병원균 검출에서 토양 오염 물질의 식별에 이르기까지 광범위하게 적용되고 있습니다. PCR과 NGS는 수돗물내 미생물 오염 검출, 생물다양성 평가, 외래종 확산 모니터링 등에 활용되고 있습니다. 이러한 방법들은 특히 기후 변화와 환경 악화에 대한 우려가 높아지는 가운데 환경 안전과 지속가능성을 향상시키고 있습니다. 정부와 조직이 보다 효과적인 환경 모니터링과 관리에 집중함에 따라 환경 과학 분야에서 분자 방법론의 채택이 확대될 것으로 예측됩니다.

이러한 새로운 동향은 기술 혁신을 촉진하고, 접근성을 향상시키며, 응용 범위를 확대함으로써 분자 측정법 시장을 재구성하고 있습니다. AI의 통합, NGS의 확대, POC(Point of Care) 진단, CRISPR의 발전, 환경 모니터링은 앞으로도 시장을 형성할 주요 동향입니다. 이러한 기술의 발전은 헬스케어, 농업, 환경 보호에 새로운 기회를 가져다 줄 것이며, 전 세계 산업을 변화시킬 것으로 보입니다.

분자 측정법 시장의 최근 동향

몇 가지 주요 개발이 분자 측정법 시장에 영향을 미치고 있으며, 기술 발전과 진단 및 연구 분야의 용도가 확대되고 있습니다.

• 신속 PCR 검사 플랫폼 개발: 최근 PCR 기술의 발전은 보다 신속하고 정확한 검사 플랫폼의 개발로 이어지고 있습니다. 이러한 플랫폼은 감염병 진단에 매우 중요한 결과를 실시간으로 제공할 수 있습니다. COVID-19 팬데믹은 신속 PCR 검사의 채택을 크게 가속화시켰고, 그 응용은 현재 다른 전염병 및 유전자 검사로 확대되고 있습니다.
• CRISPR 기반 진단 툴의 발전: CRISPR 기반 분자진단 툴의 개발은 시장에서 중요한 이정표입니다. 이러한 툴은 유전자 변이 및 병원균을 신속하고 정확하게 검출할 수 있습니다. CRISPR 진단은 몇 시간 내에 이루어지기 때문에 의료 현장에서 사용하기에 적합하며, 의료 현장에서의 진단 소요 시간을 단축할 수 있습니다.
• 임상 진단에서의 NGS 활용 증가: 차세대 염기서열분석기(NGS)는 특히 종양학 및 희귀 유전질환에서 연구뿐만 아니라 임상 진단으로 확대되고 있습니다. NGS는 종합적인 유전학적 인사이트를 제공하여 보다 개인화된 치료 계획을 가능하게 합니다. NGS의 비용이 지속적으로 하락함에 따라 임상 현장의 표준 툴이 되어 진단 정확도와 치료 효과가 향상될 것으로 기대되고 있습니다.
• 지속가능한 농업을 위한 분자 기법: 질병 감지, 해충 관리, 작물 유전자 변형 등 농업의 과제를 해결하기 위해 분자 기법이 점점 더 많이 활용되고 있습니다. 식물 병원균을 검출하는 분자진단 툴의 개발로 식량안보가 향상되고 있습니다. 또한 병해충에 대한 저항성을 높인 유전자 변형 작물 생산에도 분자적 기법이 적용되어 지속가능한 농업에 기여하고 있습니다.
• 현장진단기기의 발전: 특히 감염성 질환에 대한 현장진단(POC, Point of Care) 분자진단기기의 개발이 크게 진전되고 있습니다. 이러한 휴대용으로 사용하기 편리한 장비는 현장 검사를 가능하게 하여 검사 시설의 필요성을 제거합니다. POC 진단의 성장으로 농촌 및 자원이 부족한 지역에서도 분자 검사가 더욱 친숙해져 전 세계 의료 성과가 향상되고 있습니다.

이러한 주요 개발은 진단의 속도, 정확성, 접근성을 향상시킴으로써 분자검사법 시장을 형성하고 있습니다. PCR, CRISPR, NGS, POC 진단의 혁신은 헬스케어와 농업을 변화시키고 있으며, 분자 검사법을 보다 효율적이고 광범위하게 채택할 수 있도록 하고 있습니다.

목차

제1장 개요

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 거시경제 동향과 예측
• 산업 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 분자 측정법 시장(유형별)

• 개요
• 유형별 매력 분석
• 중합효소 연쇄 반응(PCR) : 동향과 예측(2019-2031년)
• 면역측정 : 동향과 예측(2019-2031년)
• 바이오 센서 : 동향과 예측(2019-2031년)
• 마이크로어레이 : 동향과 예측(2019-2031년)
• 기타 : 동향과 예측(2019-2031년)

제5장 세계의 분자 측정법 시장(용도별)

• 개요
• 용도별 매력 분석
• 연구 리포트 : 동향과 예측(2019-2031년)
• 시약·소모품 : 동향과 예측(2019-2031년)
• 서비스 : 동향과 예측(2019-2031년)

제6장 지역 분석

• 개요
• 지역의 분자 측정법 시장

제7장 북미의 분자 측정법 시장

• 개요
• 북미의 분자 측정법 시장(유형별)
• 북미의 분자 측정법 시장(용도별)
• 미국의 분자 측정법 시장
• 멕시코의 분자 측정법 시장
• 캐나다의 분자 측정법 시장

제8장 유럽의 분자 측정법 시장

• 개요
• 유럽의 분자 측정법 시장(유형별)
• 유럽의 분자 측정법 시장(용도별)
• 독일의 분자 측정법 시장
• 프랑스의 분자 측정법 시장
• 스페인의 분자 측정법 시장
• 이탈리아의 분자 측정법 시장
• 영국의 분자 측정법 시장

제9장 아시아태평양의 분자 측정법 시장

• 개요
• 아시아태평양의 분자 측정법 시장(유형별)
• 아시아태평양의 분자 측정법 시장(용도별)
• 일본의 분자 측정법 시장
• 인도의 분자 측정법 시장
• 중국의 분자 측정법 시장
• 한국의 분자 측정법 시장
• 인도네시아의 분자 측정법 시장

제10장 기타 지역의 분자 측정법 시장

• 개요
• 기타 지역의 분자 측정법 시장(유형별)
• 기타 지역의 분자 측정법 시장(용도별)
• 중동의 분자 측정법 시장
• 남미의 분자 측정법 시장
• 아프리카의 분자 측정법 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업 간 경쟁 관계
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 대체품의 위협
  • 신규 진출업체의 위협
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계의 분자 측정법 시장에서의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증과 라이선싱
  • 합병, 인수, 계약, 제휴, 합병사업

제13장 밸류체인 전체에 걸친 주요 기업의 기업 개요

• 경쟁 분석
• Qiagen
• 3M
• Veredus Laboratories
• Neogen Corporation
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• BioMerieux
• Archerdx
• Himedia Laboratories
• Eurofins Scientific

제14장 부록

• 도표
• 표 리스트
• 조사 방법
• 면책사항
• 저작권
• 약어와 기술 단위
• Lucintel 소개
• 문의처

영문목차

The future of the global molecular method market looks promising with opportunities in the instrument, reagents & consumables, and services markets. The global molecular method market is expected to grow with a CAGR of 6.1% from 2025 to 2031. The major drivers for this market are the rising demand for personalized medicine and increased research in genomics and biotechnology.

• Lucintel forecasts that, within the type category, polymerase chain reaction (PCR) is expected to witness the highest growth over the forecast period.
• Within the application category, reagents & consumables are expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Molecular Method Market

The molecular method market is evolving rapidly due to technological advancements and increasing applications in various industries. Several trends are reshaping the landscape, enhancing diagnostic capabilities, and expanding the scope of molecular methods.

• Integration of Artificial Intelligence (AI) in Molecular Diagnostics: AI is transforming molecular diagnostics by improving the accuracy of data analysis and interpretation. In combination with molecular techniques like PCR and NGS, AI algorithms can identify patterns in genetic data, which aids in diagnosing diseases such as cancer and genetic disorders more effectively. AI-driven solutions are also being used to improve the speed of testing and reduce human error, enabling healthcare providers to make more timely and accurate decisions. As AI technologies continue to evolve, they will play a significant role in revolutionizing molecular diagnostics.
• Expansion of Next-Generation Sequencing (NGS) Applications: NGS technologies are expanding beyond genetic research into clinical diagnostics, particularly in oncology, genetics, and rare diseases. NGS allows for more comprehensive and detailed genetic analysis, which enables precision medicine. The growing affordability and accessibility of NGS platforms are driving their use in clinical settings, facilitating early disease detection and personalized treatment plans. With the increasing volume of genetic data, NGS is becoming a key tool in molecular diagnostics and therapeutic decision-making.
• Point-of-Care Molecular Diagnostics: The demand for point-of-care (POC) molecular diagnostics has been rising, especially in response to the need for rapid, on-site testing during the COVID-19 pandemic. These portable devices enable immediate testing and results without requiring a laboratory setting, which is particularly valuable in rural or underserved areas. POC molecular diagnostics are being increasingly used in infectious disease detection, genetic testing, and monitoring of chronic conditions. The trend toward miniaturization of molecular diagnostic tools is likely to drive further growth in this area, making testing more accessible and efficient.
• Advancements in CRISPR Technology for Molecular Diagnostics: CRISPR gene-editing technology is revolutionizing molecular diagnostics by enabling more precise and efficient detection of specific genetic sequences. Researchers are developing CRISPR-based diagnostic tools that can quickly and accurately detect pathogens and genetic mutations. These advancements promise to improve early disease detection and offer potential solutions for personalized medicine. The integration of CRISPR into molecular diagnostics is a significant trend that could lead to faster and more affordable diagnostic tools, benefiting both healthcare and agriculture.
• Molecular Methods in Environmental Monitoring: The use of molecular methods in environmental monitoring is growing, with applications ranging from detecting pathogens in water to identifying pollutants in soil. PCR and NGS are being used to detect microbial contamination in water supplies, assess biodiversity, and monitor the spread of invasive species. These methods are improving environmental safety and sustainability, particularly as concerns about climate change and environmental degradation increase. The adoption of molecular methods in environmental sciences is expected to grow as governments and organizations focus on more effective environmental monitoring and management.

These emerging trends are reshaping the molecular methods market by driving innovation, improving accessibility, and expanding the scope of applications. AI integration, NGS expansion, point-of-care diagnostics, CRISPR advancements, and environmental monitoring are key trends that will continue to shape the market. As these technologies advance, they will unlock new opportunities for healthcare, agriculture, and environmental protection, transforming industries worldwide.

Recent Developments in the Molecular Method Market

Several key developments are influencing the molecular method market, with technological advancements and growing applications in diagnostics and research.

• Development of Rapid PCR Testing Platforms: Recent advancements in PCR technology have led to the development of faster and more accurate testing platforms. These platforms can deliver results in real-time, which is crucial for infectious disease diagnostics. The COVID-19 pandemic significantly accelerated the adoption of rapid PCR tests, and their application is now expanding to other infectious diseases and genetic testing.
• Advancements in CRISPR-based Diagnostic Tools: The development of CRISPR-based molecular diagnostic tools is a significant milestone in the market. These tools allow for rapid and accurate detection of genetic mutations and pathogens. CRISPR diagnostics can be done in a matter of hours, making them ideal for use in point-of-care settings and reducing diagnostic turnaround times in healthcare.
• Increased Use of NGS in Clinical Diagnostics: Next-generation sequencing (NGS) is expanding beyond research into clinical diagnostics, particularly in oncology and rare genetic disorders. NGS offers comprehensive genetic insights, enabling more personalized treatment plans. As the cost of NGS continues to decrease, it is expected to become a standard tool in clinical settings, improving diagnostic accuracy and treatment efficacy.
• Molecular Methods for Sustainable Agriculture: Molecular methods are increasingly being used to address challenges in agriculture, including disease detection, pest management, and genetic modification of crops. The development of molecular diagnostic tools for detecting plant pathogens is improving food security. Molecular methods are also being employed to create genetically modified crops that are more resistant to pests and diseases, contributing to sustainable agriculture.
• Advancements in Point-of-Care Diagnostic Devices: There has been a significant increase in the development of point-of-care (POC) molecular diagnostic devices, especially for infectious diseases. These portable and user-friendly devices enable on-site testing, eliminating the need for laboratory facilities. The growth of POC diagnostics is making molecular testing more accessible in rural and low-resource areas, improving global healthcare outcomes.

These key developments are shaping the molecular methods market by improving diagnostic speed, accuracy, and accessibility. Innovations in PCR, CRISPR, NGS, and point-of-care diagnostics are transforming healthcare and agriculture, making molecular methods more efficient and widely adopted.

Strategic Growth Opportunities in the Molecular Method Market

The molecular method market offers numerous growth opportunities across a variety of applications. As new technologies emerge, the potential for growth in healthcare, agriculture, and environmental monitoring expands.

• Cancer Diagnostics and Treatment: Molecular methods are playing a key role in cancer diagnosis and treatment, with technologies such as PCR, NGS, and CRISPR being used to identify genetic mutations and biomarkers specific to various cancers. These tools enable early detection, personalized treatment, and better monitoring of treatment efficacy. The continued development of molecular methods in oncology presents significant growth opportunities.
• Infectious Disease Detection and Monitoring: The demand for molecular methods in the detection and monitoring of infectious diseases has skyrocketed, particularly in response to the COVID-19 pandemic. PCR and other molecular techniques are becoming essential tools for diagnosing diseases like tuberculosis, HIV, and Zika virus. The growing need for rapid diagnostics and surveillance tools in infectious disease control offers significant market growth potential.
• Agricultural Biotechnology: Molecular methods are being increasingly used in agriculture for disease detection, pest management, and crop improvement. The development of genetically modified crops and more efficient pest control methods is driving the use of molecular diagnostics in the agricultural sector. This presents significant opportunities for growth in agricultural biotechnology, particularly in developing countries where food security is a priority.
• Personalized Medicine and Genomic Research: The move toward personalized medicine, where treatments are tailored to an individual's genetic profile, is driving growth in genomic research and diagnostics. Molecular methods such as NGS and CRISPR-based technologies are enabling more accurate diagnoses and targeted therapies. This growing field presents significant growth opportunities for companies developing molecular diagnostic tools.
• Environmental Monitoring and Sustainability: As concerns about climate change and environmental degradation rise, molecular methods are being increasingly used for environmental monitoring. These methods help detect pollutants, monitor biodiversity, and track the spread of invasive species. The demand for molecular tools in environmental science and sustainability is expected to grow as environmental protection becomes a higher priority worldwide.

The molecular methods market offers strategic growth opportunities in various sectors, including healthcare, agriculture, and environmental monitoring. By focusing on applications such as cancer diagnostics, infectious disease detection, and sustainable agriculture, the molecular methods market is poised for continued expansion and innovation.

Molecular Method Market Driver and Challenges

The molecular methods market is influenced by technological, economic, and regulatory factors that drive growth and pose challenges.

The factors responsible for driving the molecular method market include:

1. Technological Advancements: Advances in molecular technologies like PCR, NGS, and CRISPR are driving the market by enabling more accurate and rapid diagnostics. These innovations enhance disease detection and treatment planning, particularly in oncology, infectious diseases, and genetics.

2. Increased Demand for Early Disease Detection: As healthcare systems prioritize early detection and prevention, molecular methods are in high demand. Technologies that enable early diagnosis of conditions like cancer, genetic disorders, and infectious diseases are seeing significant growth.

3. Personalized Medicine: Personalized medicine is driving the adoption of molecular methods by offering tailored treatment plans based on genetic and molecular profiles. Technologies like NGS and CRISPR are essential for delivering personalized therapies.

4. Expanding Applications in Agriculture: Molecular methods are increasingly being used in agriculture for pathogen detection, pest management, and the development of genetically modified crops. This shift toward molecular-based agriculture is driving growth in the sector.

5. Rising Healthcare Expenditure: Global increases in healthcare spending are contributing to the adoption of advanced diagnostic technologies, including molecular methods. As healthcare providers invest in state-of-the-art diagnostic tools, the market for molecular methods expands.

Challenges in the molecular method market are:

1. High Costs of Molecular Methods: The cost of advanced molecular methods, including PCR, NGS, and CRISPR, remains a barrier to adoption in many regions. High costs can limit access to these technologies, particularly in low-income areas.

2. Regulatory Hurdles: The complex and varied regulatory requirements across countries pose challenges for the market. Different approval processes for molecular diagnostic devices and treatments can delay product launches and market entry.

3. Limited Awareness and Education: In some regions, there is limited awareness of the benefits and capabilities of molecular methods. Educating healthcare professionals and the public about the value of these technologies is crucial to driving adoption.

The molecular methods market is driven by technological advancements, increased demand for early disease detection, and the rise of personalized medicine. However, challenges such as high costs, regulatory barriers, and limited awareness need to be addressed to unlock the full potential of the market. Overcoming these challenges will support the continued growth and widespread adoption of molecular methods.

List of Molecular Method Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies molecular method companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the molecular method companies profiled in this report include-

• Qiagen
• 3M
• Veredus Laboratories
• Neogen Corporation
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• BioMerieux
• Archerdx
• Himedia Laboratories
• Eurofins Scientific

Molecular Method Market by Segment

The study includes a forecast for the global molecular method market by type, application, and region.

Molecular Method Market by Type [Value from 2019 to 2031]:

• Polymerase Chain Reaction (PCR)
• Immunoassay
• Biosensors
• Microarray
• Other

Molecular Method Market by Application [Value from 2019 to 2031]:

• Instrument
• Reagents & Consumables
• Services

Molecular Method Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Molecular Method Market

The molecular methods market has seen significant advancements in recent years due to innovations in diagnostic tools, biotechnology, and research methodologies. These techniques are pivotal in numerous sectors, including healthcare, agriculture, and environmental science. As the demand for more accurate and rapid testing grows, the molecular methods market has expanded globally. The United States, China, Germany, India, and Japan are key players in this market, each contributing unique advancements and driving innovation in their respective regions. In this overview, we will explore the recent developments within these countries.

• United States: In the United States, molecular methods, particularly PCR (polymerase chain reaction) and next-generation sequencing (NGS), continue to lead to advancements in genetic testing, diagnostics, and personalized medicine. The COVID-19 pandemic significantly boosted the demand for molecular diagnostics, accelerating innovation in the development of rapid testing solutions. Furthermore, the integration of AI and machine learning in molecular diagnostics is gaining traction, enabling better data interpretation and faster diagnoses. The U.S. is also focusing on expanding research into CRISPR gene editing techniques, which will significantly impact various fields, including agriculture and healthcare.
• China: China is increasingly focusing on expanding its molecular method capabilities in both healthcare and agricultural sectors. The country has made significant strides in NGS and PCR technologies, particularly for the early detection of infectious diseases and genetic conditions. The Chinese government has also invested heavily in biotechnology research, aiming to improve diagnostics and healthcare infrastructure. Additionally, China is leading efforts to develop molecular methods for agricultural applications, including the detection of plant pathogens and the development of genetically modified crops, which could further boost food security and sustainability.
• Germany: Germany is at the forefront of applying molecular methods in diagnostics and research, with significant contributions to PCR and NGS technologies. The country's strong biotech industry is driving innovations in molecular diagnostics, particularly in oncology and infectious diseases. Researchers in Germany are developing cutting-edge molecular tools to detect genetic mutations and markers associated with various cancers, enabling earlier detection and more effective treatments. Germany is also focusing on expanding its research in molecular biology for agricultural uses, including the development of sustainable farming practices through molecular methods.
• India: The Indian molecular methods market is rapidly evolving, driven by the need for affordable diagnostic solutions and advancements in biotechnology. PCR technology is widely used for diagnosing infectious diseases, including tuberculosis and COVID-19. However, India still faces challenges with access to high-quality molecular diagnostic tools in rural areas. Efforts are being made to develop more cost-effective molecular testing platforms and expand access across the country. India is also focusing on the research and development of molecular methods for improving crop yield and pest management in agriculture.
• Japan: Japan remains a leader in molecular research, particularly in healthcare and agriculture. The country is heavily investing in advancements in molecular diagnostic tools for early detection of diseases like cancer, Alzheimer's, and cardiovascular diseases. Japan's molecular biology research is advancing the use of gene-editing tools such as CRISPR-Cas9. Additionally, the country is making strides in molecular methods for enhancing food security by developing more robust crops and improving food safety through pathogen detection technologies. Japan's continued investments in biotechnology ensure its leadership in innovation of molecular methods.

Features of the Global Molecular Method Market

• Market Size Estimates: Molecular method market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Molecular method market size by type, application, and region in terms of value ($B).
• Regional Analysis: Molecular method market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the molecular method market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the molecular method market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the molecular method market by type (polymerase chain reaction (PCR), immunoassay, biosensors, microarray, and other), application (instrument, reagents & consumables, and services), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Molecular Method Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Polymerase Chain Reaction (PCR): Trends and Forecast (2019-2031)
• 4.4 Immunoassay: Trends and Forecast (2019-2031)
• 4.5 Biosensors: Trends and Forecast (2019-2031)
• 4.6 Microarray: Trends and Forecast (2019-2031)
• 4.7 Other: Trends and Forecast (2019-2031)

5. Global Molecular Method Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Instrument: Trends and Forecast (2019-2031)
• 5.4 Reagents & Consumables: Trends and Forecast (2019-2031)
• 5.5 Services: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Molecular Method Market by Region

7. North American Molecular Method Market

• 7.1 Overview
• 7.2 North American Molecular Method Market by Type
• 7.3 North American Molecular Method Market by Application
• 7.4 United States Molecular Method Market
• 7.5 Mexican Molecular Method Market
• 7.6 Canadian Molecular Method Market

8. European Molecular Method Market

• 8.1 Overview
• 8.2 European Molecular Method Market by Type
• 8.3 European Molecular Method Market by Application
• 8.4 German Molecular Method Market
• 8.5 French Molecular Method Market
• 8.6 Spanish Molecular Method Market
• 8.7 Italian Molecular Method Market
• 8.8 United Kingdom Molecular Method Market

9. APAC Molecular Method Market

• 9.1 Overview
• 9.2 APAC Molecular Method Market by Type
• 9.3 APAC Molecular Method Market by Application
• 9.4 Japanese Molecular Method Market
• 9.5 Indian Molecular Method Market
• 9.6 Chinese Molecular Method Market
• 9.7 South Korean Molecular Method Market
• 9.8 Indonesian Molecular Method Market

10. ROW Molecular Method Market

• 10.1 Overview
• 10.2 ROW Molecular Method Market by Type
• 10.3 ROW Molecular Method Market by Application
• 10.4 Middle Eastern Molecular Method Market
• 10.5 South American Molecular Method Market
• 10.6 African Molecular Method Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Molecular Method Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Qiagen
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 3M
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Veredus Laboratories
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Neogen Corporation
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Thermo Fisher Scientific
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Bio-Rad Laboratories
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 BioMerieux
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Archerdx
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Himedia Laboratories
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 Eurofins Scientific
  • Company Overview
  • Molecular Method Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us